The experts set up an international initiative called COVAX (COVID-19 Vaccines Global Access initiative), designed to make sure that every country in the world gets access to vaccines regardless of its ability to pay. Almost a year-and-a-half into the pandemic, here’s a look at the current status of the highly ambitious global vaccination programme.
India has pushed the pedal on its Covid-19 vaccine drive. The country has begun inoculating its elderly citizens against Covid-19 in the second phase of the world’s largest vaccination drive on Monday. In this phase, people above the age of 60 years and those above 45 years who are in the high-risk category will be administered the jab. Here’s everything you need to know about the world’s largest Covid vaccination drive.
After months of fretting over whether a COVID-19 vaccine would even be possible, we now have almost five promising vaccine candidates. Moreover, the nation has initiated action plans to take the vaccine from warehouses to the upper shoulders of millions of people in the country whenever it becomes available. Yes! there’s still a long way to go, but how far are we from a vaccine for the novel coronavirus now? Let’s look into it
It was recently that the country came up with its first indigenous COVID-19 vaccine candidate, named ‘Covaxin’. The Drug Controller General of India’s approval to conduct human trials of Covaxin — developed jointly by Bharat Biotech, National Institute of Virology and the Indian Council of Medical Research — has sparked a glimmer of hope but then a circular last week turned that hope into fear of hasty approach.